Search results
Results from the WOW.Com Content Network
Sir Bruce Anthony John Ponder FMedSci FAACR FRS FRCP (born 25 April 1944) is an English geneticist and cancer researcher. He is Emeritus Professor of Oncology at the University of Cambridge and former director of the Cancer Research UK Cambridge Institute and of the Cancer Research UK Cambridge Cancer Centre.
The paper outlines a 10-point plan to improve cancer care, and calls for the creation of a UK-wide national cancer control plan, along with a prevention programme for smoking, obesity and alcohol ...
She specialises in research into the genetic mechanisms that cause cancer, particularly among groups with a predisposition to pediatric cancers or breast cancer. [8] Through her research, Professor Rahman has provided improved screening and treatment options for NHS patients, and also provides advice on rare cancer genetics to clinicians ...
Robert Charles Swanton is a British physician scientist specialising in oncology and cancer research.Swanton is a senior group leader at London's Francis Crick Institute, [3] Royal Society Napier Professor in Cancer [4] and thoracic medical oncologist at University College London [5] and University College London Hospitals, [6] [7] co-director of the Cancer Research UK (CRUK) Lung Cancer ...
Carroll's research uses molecular, genomic and proteomic approaches to understand how the Estrogen Receptor causes gene transcription and how this contributes to breast cancer progression. [5] In 2008, Carroll discovered the molecular mechanism of tamoxifen in breast cancer, demonstrating that tamoxifen switched off the breast cancer gene ErbB2 ...
Drinking more than four cups of caffeinated coffee in a day was associated with a lower risk for head and neck cancer, oral cavity cancer, and oropharyngeal cancers compared to not drinking coffee.
The Medical Research Council (UK) Human Genetics Unit is situated at the Western General Hospital in Edinburgh. It is one of the largest MRC research establishments, housing over two hundred scientists, support staff, research fellows, PhD students, and visiting workers.
Paul Workman. Workman was born on 30 March 1952 in Workington, Cumbria, England. [2] He was educated at Workington County Grammar School, Cumbria, and completed his BSc degree in Biochemistry at the University of Leicester and his PhD degree in Cancer Pharmacology at the University of Leeds.